The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(4-(2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)piperazin-1-yl)-3-oxopropyl)pentanamide ID: ALA5287860
Chembl Id: CHEMBL5287860
Max Phase: Preclinical
Molecular Formula: C28H32FN7O3
Molecular Weight: 533.61
Associated Items:
Names and Identifiers Canonical SMILES: CCCCC(=O)NCCC(=O)N1CCN(c2ccc3nc(-c4cc(F)c5nc(C)cn5c4)cc(=O)n3c2)CC1
Standard InChI: InChI=1S/C28H32FN7O3/c1-3-4-5-25(37)30-9-8-26(38)34-12-10-33(11-13-34)21-6-7-24-32-23(15-27(39)36(24)18-21)20-14-22(29)28-31-19(2)16-35(28)17-20/h6-7,14-18H,3-5,8-13H2,1-2H3,(H,30,37)
Standard InChI Key: MPRWZXZMPNMIKN-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 533.61Molecular Weight (Monoisotopic): 533.2551AlogP: 2.80#Rotatable Bonds: 8Polar Surface Area: 104.32Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.50CX LogP: 0.47CX LogD: 0.47Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.37Np Likeness Score: -1.85
References 1. Palacios DS.. (2022) Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic Modalities., 65 (20.0): [PMID:36206538 ] [10.1021/acs.jmedchem.2c01491 ]